|
|
||||||||
1 Department of Molecular Pharmacology and Biological Chemistry and
2 Drug Discovery Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
3 C.H. Best Institute, University of Toronto, Toronto ON M5G 1L6, Canada
Reprint requests to: Wayne F. Anderson, Northwestern University Feinberg School of Medicine, 303 E. Chicago Avenue, Ward Building Room 8-264, Chicago, IL 60611, USA; e-mail: wf-anderson{at}northwestern.edu; fax: (312) 503-5349.
(RECEIVED January 16, 2003; FINAL REVISION April 7, 2003; ACCEPTED April 14, 2003)
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.0302403.
| Abstract |
|---|
|
|
|---|
Keywords: X-ray crystal structure; methyltransferase; AdoMet; AdoHcy; cell division; MraW
| Introduction |
|---|
|
|
|---|
The substrate for the methylation reaction of COG0275 members has not been determined, but is expected to be conserved. TM0872 sequence homologs are found in many bacteria and in eukaryotes such as Arabadopsis, Drosophila, mice, and humans. Except for the small number of residues believed to mediate AdoMet binding, the TM0872 sequence family contains no significant sequence homology to the numerous characterized MTs with varied MT substrate specificities. However, in E. coli, MraW is located in an operon that encodes genes involved in cell wall metabolism and cell division, suggesting that the target of MraW may be involved in these cellular events. Other proteins in the same operon have been characterized, and include the peptidoglycan biosynthesis enzymes ftsI, MurE, MurD, MurG, MurC, MraY, and ddIB, and the cell division proteins ftsL, ftsW, ftsQ, ftsA, ftsZ, and mraZ. Interestingly, low levels of AdoMet result in a partial cell division block in E. coli (Newman et al. 1998).
As part of the Midwest Center for Structural Genomics (MCSG) initiative (www.mcsg.anl.gov), we have determined two crystal structures of TM0872, one in complex with AdoMet, and the other with AdoHcy, each at 1.9 Å resolution. As predicted, the structure of TM0872 reveals a typical AdoMet binding domain, which binds endogenous AdoMet or co-crystallized AdoHcy in a manner consistent with other known MT structures. In addition, there is a unique second domain, which presumably facilitates selection of the unknown methyl acceptor. We also identified a potential substrate-binding cleft spanning the AdoMet domain and the unique second domain. However, the conformation of the protein in our structures is inconsistent with methyl group transfer. AdoMet and AdoHcy are both largely buried, and access to the reactive methyl group would presumably require structural rearrangement.
| Results and Discussion |
|---|
|
|
|---|
Model completeness and quality
Seleno-L-methionine-substituted TM0872 was co-crystallized with AdoHcy for structure determination using MAD phasing (Hendrickson et al. 1985). AdoHcy (0.3 mM) was added because the protein was suspected to be an AdoMet-dependent MT. Because the protein copurified with AdoMet or a mixture of AdoMet and AdoHcy (see below), these crystals are likely to contain a mixture of AdoHcy and AdoMet. The crystal belongs to the cubic space group P213 with cell dimensions a=b=c= 133.4 Å, and
=ß=
= 90 degrees. There are two polypeptides per asymmetric unit. In general, the density for molecule A is better defined than for molecule B, perhaps due to differences in crystal packing. Molecule A makes extensive crystal contacts; molecule B does not. Molecule A residues Se-Met A1 and A295A299 at the C terminus were disordered, and therefore were not included in the model. Molecule B residues B1B8, loop residues B274B280, and C-terminal residues B293B299 were also not incorporated, due to poor electron density in these regions. In addition, two residues that precede Se-Met 1 and derive from the fusion protein were not observed in either A or B molecules. Residues with incomplete side-chain density were modeled as alanines. These include residues A2, B14, B15, B23B26, B35, B69, B238, B272, B282, B284, B287, and B292. According to PROCHECK analysis (Laskowski et al. 1993), 87.2% of the protein is in the most favored Ramachandran plot region, and two residues, Asp 24 from A and Glu 23 from B, are in the disallowed region. The final Rwork is 19.7, and Rfree is 21.2. Representative electron density is shown in Figure 1
. The electron density indicates that the complex is predominately AdoHcy, and the ligand was modeled as AdoHcy. The final 1.9 Å TM0872-AdoHcy model contains 569 protein residues, two AdoHcy molecules, two sulfate ions, and 367 water molecules.
|
=ß=
= 90.0 degrees, contained AdoMet or a mixture of AdoMet and AdoHcy that copurified with the protein. The electron density indicated that the ligand in this complex was predominately AdoMet, and was modeled as such. The final 1.9 Å TM0872-AdoMet model contains 562 residues, two AdoMet molecules, two sulfate ions, and 349 water molecules. The crystal contacts seen in the TM0872-AdoHcy model are maintained, again leading to a better defined density for molecule A compared to molecule B. Poor electron density prohibited assignment of molecule A residues A1A7 and A295A299 at the C terminus, as well as molecule B residues B1B8, loop residues B274B280, and C-terminal residues B293B299. As for TM0872-AdoHcy, the residues preceding the N terminus were not observed in molecules A and B. Residues modeled as alanines due to incomplete side-chain density include those listed for the TM0872-AdoHcy final model, plus B90 and B95. PROCHECK assessment of model quality assigns 90.2% of the protein to the most favored Ramachandran plot region, and no residues to the disallowed region. The final Rwork is 20.5, and Rfree is 22.6. A summary of data collection and refinement statistics is given in Table 1
|
/ß core AdoMet binding domain. In addition, there is a unique second domain, which is inserted in the middle of the protein sequence and is thought to affect target selectivity. A ribbon diagram of the TM0872-AdoHcy complex is given in Figure 2
|
/ß AdoMet domain, there are notable topological differences among MT structures. For example, the
-helix between ß1 and ß4 originates from the N terminus in TM0872 (
1), but consists of C-terminal residues in some MTs. In addition, TM0872 and rat catechol-O MT (Vidgren et al. 1994) have relatively simple AdoMet domains, whereas others may have additional
-helices and/or ß-strands flanking the central ß-sheet. The length of the ß-strands can also differ; ß6 of TM0872 is greatly reduced in length, resulting in an extensive random coil region before and after this short ß-strand.
TM0872 has a second domain that is novel among MTs in both its location in the sequence and its structure. We presume that this domain facilitates selection of the unknown methyl acceptor. The roughly 110-amino-acid (aa) domain is inserted between ß4 and ß5 of the AdoMet domain, which is simply a loop connection or a single
-helix in all other MT structures known to date (Martin and McMillan 2002). Of the known MT structures, the recognition domains are most often inserted at the N or C terminus of the protein. However, more complex topological arrangements are also possible. For instance, the recognition domain of mycolic acid cyclopropane synthases from M. tuberculosis consists of
-helices inserted after ß5 and ß6 of the AdoMet domain (Huang et al. 2002). The second domain of TM0872 is also unusual in its structure. A DALI search of the PDB database using this
-helical domain (
2
8) identifies no structures with significant similarity.
TM0872 AdoMet binding motifs and specific interactions
The superposition of TM0872-AdoMet with other MT complexes shows that the ligands superimpose to the same degree as the AdoMet domains. Specifically, AdoMet is oriented to interact with protein residues near the C terminus of ß-strands 1 through 4. Although there is a strong spatial correlation of AdoMet binding regions, the sequence identity of specific residues contacting AdoMet varies among different MT sequence families. The TM0872 sequence family appears to have little sequence conservation with other MTs. Even so, we have identified four AdoMet-binding motifs that have spatial and functional homology with other MTs.
AdoHcy-TM0872 interactions are shown in Figure 3
, and described in Table 2
. Motif I is the most common AdoMet binding signature, a glycine-rich loop region between ß1 and
A with consensus 30DxTxGxG/AGH38. This region forms the binding pocket surrounding the L-homocysteine portion of AdoHcy. In the case of TM0872, Glu 35, Gly 36, Gly 37, and His 38 all make hydrogen bonds to the carboxylate moiety of AdoHcy via their backbone NH group. Commonly, other MT structures also contain an acidic residue at the end of ß2, which forms hydrogen bonds with the ribose hydroxyls of AdoHcy. In TM0872, the key motif II residue is Asp 55, which interacts strongly with O2' and O3' hydroxyls and is found within the consensus sequence 55DxD57. Val 56 is in Van der Waals contact with the adenine ring. Although this residue is often a hydrophobic residue performing the same function in other MTs, it is most often an arginine or glutamine in other TM0872 family members. Asp 57 does not directly interact with AdoHcy, but instead may act in a supportive role by orienting Asp 55 and the conserved Gln 110, which hydrogen-bonds to the O2' hydroxyl group of AdoHcy. Motif III binds the adenine ring, and is located in the ß3
C loop region. Ser 81 and Tyr 82 satisfy the motif III criteria, although the only sequence conservation (among TM0872 family members) consists of a tyrosine or phenylalanine residue at position 82. The O
H of Ser 81 and the mainchain NH of Tyr 82 form hydrogen bonds to N1 and N6 of adenine, respectively. In addition, the Tyr 82 ring and the adenine ring form a
-stacking interaction. Motif IV, with the consensus sequence 103DLGxS107, consists of residues from ß4 (Asp 103 and Leu 104), and the loop connecting the AdoMet and "recognition" domains (Gly 105Ser 107). These residues form the binding pocket around the amino acid of AdoHcy, and Asp 103 forms a hydrogen bond with the NH3 of AdoHcy.
|
|
2) at the beginning of the second domain, the side chain of Gln 110 reaches across the domain divide to contact the ribose O2' hydroxyl. Found among a well conserved stretch of amino acids in the long
2
3 loop (126LDMRM130), Se-Met 130 is in van der Waals contact with both the adenine and ribose. In addition, residues Asn 216, Glu 218, and Asn 221 help establish the adenine-binding pocket. Residues Asn 216 and Glu 218 are part of a conserved stretch of amino acids starting in
8, and ending in
D of the AdoMet domain. The consensus sequence is 208FQA/GxRIxI/VNxEL219. Last, conserved Arg 282 from the
9ß7 loop (consensus N280xRAxSA/SxxR289) lies closely below C
of L-homocysteine.
The interactions described above hold for the TM0872-AdoMet complex, with few exceptions. These differences are shown in Figure 3A
. His 8 and Arg 282 move significantly. Unlike the AdoHcy-protein complex, His 8 does not form a hydrogen bond with AdoMet, and Arg 282 now lies close to the S+-CH3 bond rather than the C
position. Motif IV residues Asp 103 to Ser 107, which lie directly across from the S+-CH3 bond, move to accommodate the methyl group. The backbone carbonyl of Leu 104 is rotated toward the S+-CH3 bond, perhaps to assist the carbonyl oxygens of Asp 103 and Gly 105 in stabilizing the positive charge on the sulfur. Asp 103 and Arg 282 side chains move into direct hydrogen-bonding distance rather than coordinating indirectly via WAT 93. In the AdoHcy complex, WAT 93 is 3.5 Å away from the ligand sulfur. This position is not sterically allowed, and is not observed, in the complex that is predominately AdoMet. The two different complexes have been described as AdoHcy and AdoMet complexes. However, in both cases the crystals are likely to contain mixtures of AdoMet and AdoHcy. As is apparent from the original and final simulated annealing (SA) omit maps, the predominant species crystallized from the endogenous mixture is AdoMet. On the other hand, the protein incubated and crystallized in the presence of 0.3 mM AdoHcy clearly does not have significant density for the methyl group (Fig. 3B
).
TM0872 sequence family alignment and conservation mapping
A Clustal X (Jeanmougin et al. 1998) alignment for TM0872 and a diverse set of prokaryotic and eukaryotic homologs is shown in Figure 4
. The conserved AdoMet binding regions are marked, and the level of conservation of residues among COG0275 members (COG0275 alignment not shown) is indicated. The sequence alignment begins with the first conserved residue, His 8 in the TM0872 sequence. Most proteins have fewer than 20 amino acids prior to His 8, although A. thaliana has 80 extra residues. The C-termini, shown in their entirety, are of similar length. The insertions and deletions among members are all located in TM0872 loop regions. Most of these consist of only a few amino acids; however, the region around ß6 varies by as much as 43 aa in length. TM0872 has the fewest number of residues in this region, and the eukaryotic proteins have the most. The sequence conservation among TM0872 family members is generally distributed throughout the length of the sequence.
|
|
Although we have located a potential substrate-binding cleft, the conformation of the protein in our structures seems inconsistent with catalysis. The methyl donor, in absence of the substrate, is simply inaccessible. However, as was shown for C5-cytosine MT complexed with duplex DNA, substrate binding of TM0872 might be accomplished through an induced-fit mechanism (Cheng et al. 1993; Klimasauskas et al. 1994; Kumar et al. 1997; OGara et al. 1999). In order for a large substrate to access the reactive methyl group of TM0872, a structural rearrangement is necessary. Modeling suggests that movement of N-terminal residues including His 8, adjacent
9ß7 loop residues including Arg 282, and ß4
2 residues Asp 103 to Thr 108 could make a large enough tunnel for a long and narrow methyl acceptor, such as a lysine or a "flipped" base, to access the methyl group from the binding cleft. There is structural evidence that such a rearrangement is plausible. First, these residues exhibit the greatest conformational changes when AdoHcy replaces AdoMet. Figure 6
is a superposition of the AdoHcy and AdoMet protein complexes. AdoMet and AdoHcy adopt virtually the same conformation when bound to the protein, make contact via nearly identical amino acids, and the overall rmsd for the protein is about 0.5 Å for C
positions. However, conserved methyl sequestering residues and the substrate cleft in proximity to the S+-CH3 bond expand and shift in a non-uniform fashion, resulting in as much as 1.6 Å differences in C
coordinates, and 5.0 Å for side-chain atoms. In addition, the N-terminal residues observed in TM0872-AdoHcy are disordered and cannot be placed in the AdoMet complex, suggesting that this region is flexible.
|
In summary, TM0872 belongs to a large sequence family with diverse phylogenetic members. These proteins are predicted MTs, and our structural findings are consistent with this functional prediction. TM0872 has a two-domain structure and a novel topology. The AdoMet domain consists of the first and last thirds of the protein length, and a unique
-helical domain is inserted in the middle of the protein sequence after ß4. This domain is very likely to act in substrate recognition and binding. As with other MT structures, we have identified a potential substrate-binding cleft spanning the two domains. This cavity is the largest in the protein, contains the greatest number of conserved residues, and is positively charged. Although this cavity is the most reasonable candidate for substrate binding, the present structures are not consistent with methyl group transfer. AdoMet is buried, and a structural rearrangement of N-terminal residues, the adjacent
9ß7 loop, and domain linker residues will be required for access of an acceptor to the methyl group and catalysis. Future studies will probe the identity of the TM0872 sequence family methylation target.
Notes
The atomic coordinates and structure factors have been deposited in the RCSB PDB, with accession code 1M6Y
[PDB]
for the TM0872-AdoHcy complex, and 1N2X
[PDB]
for the TM0872-AdoMet complex.
| Materials and methods |
|---|
|
|
|---|
G. The selenomethionine derivative was overexpressed in E. coli BL21-Gold (DE3; Stratagene) containing an extra plasmid encoding three rare tRNAs (AGG and AGA for Arg, and ATA for Ile). The cells were grown at 37°C in 2 L of M9 minimal media according to a standard methionine production inhibition protocol, and induced with 0.4 mM IPTG at an A600 of 0.6 (Sambrook et al. 1989; Van Duyne et al. 1993). After 4 h, the cells were pelleted and resuspended in 35 mL binding buffer (50 mM HEPES pH 7.5, 5 mM imidazole, 5% glycerol, 0.5 M NaCl, and 2 mM BME). After the addition of protease inhibitors phenylmethylsulfonyl fluoride and benzamidine at 1 mM each, the resupended cells were flash-frozen in liquid nitrogen, and stored at -80°C. Thawed cells were lysed by the addition of 0.5% IGEPAL (Sigma), followed by sonication. The cell lysate was clarified by centrifugation, and the supernatant was purified at 4°C using binding, wash, and elution buffer differing only in their imidazole concentration (5, 30, and 250 mM imidazole for the binding, wash, and elution buffers, respectively). The supernatant was passed through a DE52 column equilibrated in 1M NaCl, followed by 40 mL of binding buffer. The flow-through was then applied to a 5-mL Ni2+-NTA column (Sigma). The column was washed with 200 mL of wash buffer, and the desired protein was eluted with 20 mL of elution buffer. After the addition of 1mM EDTA, his-rTEV protease was added to the eluted protein at a ratio of 60 µg protease to 1000 µg of protein, and the protease-protein sample was dialyzed overnight against 2 L of binding buffer without imidazole. The 90% cleaved protein was separated from the cut His-tag and the His-tagged TEV protease by passage through a second Ni2+ column. The purified protein was then dialyzed against 2 L of 10 mM HEPES pH 7.5, 0.5 M NaCl, 2 mM BME, filtered through a 2-µm filter, and concentrated to 20 mg/mL for crystallization.
TM0872-AdoHcy crystallization and data collection
The SeMet derivatized crystals grew by vapor diffusion in hanging drops. The initial drop contained 50 mM Na Cacodylate pH 6.5, 5 mM HEPES pH 7.5, 0.1 M Ammonium Sulfate, 9% PEG 8000, 0.25 M NaCl, 1 mM BME, 0.3 mM S-adenosyl-L-homocysteine, and 10 mg/mL protein. The well solution contained 0.1 M Na cacodylate pH 6.5, 0.2 M ammonium sulfate, and 18% PEG 8000. Crystals were observed after 10 d at 4°C. A single 0.3 x 0.3 x 0.15 mm crystal was soaked in crystallization buffer containing 25% glycerol for cryoprotection. After 5 min, the crystal was flash-cooled in liquid nitrogen. The crystal belonged to the cubic space group P213 with cell dimensions a=b=c= 133.4 Å, and
=ß=
= 90 degrees. The absorption edge of Se was determined by fluorescence. A three-wavelength MAD data set was measured at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) 5IDB Beamline at the Advanced Photon Source (APS). The 1.9 Å data with 13.7-fold redundancy were integrated using DENZO and scaled using SCALEPACK (Otwinowski and Minor 1997).
TM0872-AdoHcy initial-phase calculation and refinement
The asymmetric unit contains two protein monomers, and five seleno-methionines per monomer. Seven of the ten Se atoms in the asymmetric unit were identified by SOLVE-2.02 (Terwilliger and Berendzen 1999). The MAD map was then subjected to density modification using the RESOLVE subroutine in SOLVE-2.02, and allowed autotracing of 415 of the 602 protein residues with RESOLVE or 405 with wARP (Perrakis et al. 1999). In addition, both programs completed most of molecule A, and only the middle region (
120 residues) of molecule B. However, the wARP maps and model resulting from iterative rounds of model assignment, map calculation, and real-space torsional refinement of protein side chains were of superior quality to the twofold noncrystallographic symmetry (NCS) averaged maps and model from RESOLVE. NCS was particularly useful in the initial stages of model building and refinement in O and CNS-1.0, respectively (Jones et al. 1991; Brünger et al. 1998). Although the crystallization solution may contain residual AdoMet from protein purification, the electron density for the methyl group was not apparent. Therefore, the ligand was modeled as AdoHcy. After iterative rounds of model building in O and refinement in CNS (simulated annealing, positional minimization, water molecule identification, individual isotropic B refinement), the final Rwork is 19.7 and Rfree is 21.2. A summary of data collection and refinement statistics is given in Table 1
.
TM0872-AdoMet crystallization and data collection
TM0872-AdoMet SeMet crystals were grown and cryoprotected as described above, except that AdoHcy or AdoMet was not added. Cell dimensions are a=b=c= 133.96 Å, and
=ß=
= 90.0 degrees. A 1.9 Å single wavelength data set was collected using the 5-IDB Beamline at the APS. The 25.7-fold redundant data were processed using DENZO and SCALEPACK.
TM0872-AdoMet molecular replacement and refinement
The TM0872-AdoMet structure was solved by molecular replacement using the TM0872-AdoHcy model. The electron density was interpreted and modeled as AdoMet rather than AdoHcy. AdoMet, in these crystals, originated from the endogenous AdoMet population located within the E. coli host cells. CNS-1.0 and O were used for refinement and model building, respectively (Brünger et al. 1998; Jones et al. 1991). The final Rwork is 20.5 and Rfree is 22.6. Refer to Table 1
for data collection and refinement statistics.
Figures
Figures 1 and 3B![]()
were generated by Bobscript (Esnouf 1997) and Raster3D (Merritt and Bacon 1997). Figures 2, 3A, 5A, 5B, and 6![]()
![]()
![]()
![]()
were generated by MOLSCRIPT (Kraulis 1991) and Raster3D. Figure 4
was generated by Clustal X (Jeanmougin et al. 1998). Figures 5C
E were generated by Bonds3D (developmental software, D. Still, pers. comm.) and Raster3D.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Brünger, A.T., Adams, P.D., Clore, G.M., Delano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N.S., et al. 1998. Crystallography and NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. 54: 905921.[CrossRef]
Bujnicki, J.M. 1999. Comparison of protein structures reveals monophyletic origin of AdoMet-dependent methyltransferase family and mechanistic convergence rather than recent differentiation of N4-cytosine and N6-adenine DNA methylation. In Silico Biol. 1: 175182.[Medline]
Carrión, M., Gomez, M.J., Merchante-Schubert, R., Dongarra, S., and Ayala, J.A. 1999. mraW, an essential gene at the dcw cluster of Escherichia coli codes for a cytoplasmic protein with methyltransferase activity. Biochimie 81: 879888.[Medline]
Cheng, X. 1995. Structure and function of DNA methyltransferases. Annu. Rev. Biophys. Biomol. Struct. 24: 293318.[CrossRef][Medline]
Cheng, X., Kumar, S., Posfai, J., Pflugrath, J.W., and Roberts, R.J. 1993. Crystal structure of the HhaI DNA methyltransferase complexed with S-adenosyl-L-methionine. Cell 74: 299307.[CrossRef][Medline]
Esnouf, R.E. 1997. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. 15: 132134.[CrossRef][Medline]
Hendrickson, W.A., Smith, J.L., and Sheriff, S. 1985. Direct phase determination based on anomalous scattering. Methods Enzymol. 115: 4155.[Medline]
Holm, L., and Sander, C. 1993. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233: 123138.[CrossRef][Medline]
Huang, C.-C., Smith, C.V., Glickman, M.S., Jacobs Jr., W.R., and Sacchettini, J.C. 2002. Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis. J. Biol. Chem. 277: 1155911569.
Jeanmougin, F., Thompson, J.D., Gouy, M., Higgins, D.G., and Gibson, T.J. 1998. Multiple sequence alignment with Clustal X. Trends Biochem. Sci. 23: 403405.[CrossRef][Medline]
Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. 47: 110119.[CrossRef]
Klimasauskas, S., Kumar, S., Roberts, R.J., and Cheng, X. 1994. HhaI methyltransferase flips its target base out of the DNA helix. Cell 76: 357369.[CrossRef][Medline]
Korolev, S., Ikeguchi, Y., Skarina, T., Beasley, S., Edwards, A., Joachimiak, A., Pegg, A.E., and Savchenko, A. 2001. Nat. Struct. Biol. 9: 2731.
Kraulis, P.J. 1991. MOLSCRIPTA program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24: 946950.
Kumar, S., Horton, J.R., Jones, G.D., Walker, R.T., Roberts, R.J., and Cheng, X. 1997. DNA containing 4'thio-2'-deoxycytidine inhibits methylation by HhaI methyltransferase. Nucleic Acids Res. 25: 27732783.
Laskowski, R.A. 1995. A program for visualizing molecular surfaces, cavities, and intermolecular interactions. J. Mol. Graph. 13: 323330.[CrossRef][Medline]
Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26: 283291.
Martin, J.L. and McMillan, F.M. 2002. SAM (dependent) I AM: The S-adenosylmethionine-dependent methyltransferase fold. Curr. Opin. Struct. Biol. 12: 783793.[CrossRef][Medline]
Merritt, E.A. and Bacon, D.J. 1997. Raster3D photorealistic molecular graphics. Methods Enzymol. 277: 505524.
Newman, E.B., Budman, L.I., Chan, E.C., Greene, R.C., Lin, R.T., Woldringh, C.L., and DAri, R. 1998. Lack of S-adenosylmethionine results in a cell division defect in Escherichia coli. J. Bacteriol. 180: 36143619.
OGara, M., Zhang, X., Roberts, R.J., and Cheng, X. 1999. Structure of a binary complex of HhaI methyltransferase with S-adenosyl-L-methionine formed in the presence of a short nonspecific DNA oligonucleotide. J. Mol. Biol. 287: 201209.[CrossRef][Medline]
Otwinowski, Z. and Minor, W. 1997. Processing of X-ray diffraction data collected in oscillation mode. In Macromolecular crystallography (eds. C.W. Carter Jr. and R.M. Sweet), Vol. 276(A), pp. 307326. Academic Press, New York.
Perrakis, A., Morris, R.J., and Lamzin, V.S. 1999. Automated protein modeling combined with iterative structure refinement. Nat. Struct. Biol. 6: 458463.[CrossRef][Medline]
Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Tatusov, R.L., Natale, D.A., Garkavtsev, I.V., Tatusova, T.A., Shankavaram, U.T., Rao, B.S., Kiryutin, B., Galperin, M.Y., Fedorova, N.D., and Koonin, E.V. 1991. The COG database: New developments in phylogenetic classification of proteins from complete genomes. Nucleic Acids Res. 29: 2228.
Terwilliger, T.C. and Berendzen, J. 1999. Automated MAD and MIR structure solution. Acta Crystallogr. 55: 849861.[CrossRef]
Van Duyne, G.D., Standaert, R.F., Karplus, P.A., Schreiber, S.L., and Clardy, J. 1993. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229:105124.[CrossRef][Medline]
Vidgren, J., Svensson, L.A., and Liljas, A. 1994. Crystal structure of catechol O-methyltransferase. Nature 368: 354358.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. L. Damm and H. A. Carlson Gaussian-Weighted RMSD Superposition of Proteins: A Structural Comparison for Flexible Proteins and Predicted Protein Structures Biophys. J., June 15, 2006; 90(12): 4558 - 4573. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sun, X. Xu, M. Pavlova, A. M. Edwards, A. Joachimiak, A. Savchenko, and D. Christendat The crystal structure of a novel SAM-dependent methyltransferase PH1915 from Pyrococcus horikoshii Protein Sci., December 1, 2005; 14(12): 3121 - 3128. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Papoian, J. Ulander, M. P. Eastwood, Z. Luthey-Schulten, and P. G. Wolynes From The Cover: Water in protein structure prediction PNAS, March 9, 2004; 101(10): 3352 - 3357. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |